Clinical Trials Directory

Trials / Conditions / Marburg Virus Disease

Marburg Virus Disease

9 registered clinical trials studyying Marburg Virus Disease — 1 currently recruiting.

StatusTrialSponsorPhase
RecruitingA Phase 1 Randomized, Observer-blind, Placebo-controlled, Dose-escalation Clinical Trial to Evaluate the Safet
NCT07425821
International AIDS Vaccine InitiativePhase 1
Active Not RecruitingA Trial to Evaluate Safety, Tolerability, and Immune Responses of an Investigational Monovalent Chimpanzee Ade
NCT06620003
Albert B. Sabin Vaccine InstitutePhase 2
CompletedStudy to Evaluate the Recombinant VSV (rVSV)-Marburg Virus Vaccine Candidate (PHV01) in Healthy Adult Subjects
NCT06265012
Public Health Vaccines LLCPhase 1
CompletedMonovalent Chimpanzee Adenoviral-Vectored Marburg Virus Vaccine in Healthy Adults
NCT05817422
Albert B. Sabin Vaccine InstitutePhase 2
CompletedEvaluation of Safety, Tolerability and Immune Responses of Ebola-S and Marburg Vaccines in Healthy Adults
NCT04723602
Albert B. Sabin Vaccine InstitutePhase 1
CompletedA Study to Evaluate the Single Dose Safety, Tolerability and Pharmacokinetics of IV BCX4430
NCT03800173
BioCryst PharmaceuticalsPhase 1
CompletedcAd3-Marburg Vaccine in Healthy Adults
NCT03475056
National Institute of Allergy and Infectious Diseases (NIAID)Phase 1
CompletedEvaluating an Ebola and a Marburg Vaccine in Uganda
NCT00997607
National Institute of Allergy and Infectious Diseases (NIAID)Phase 1
CompletedEbola and Marburg Virus Vaccines
NCT00605514
National Institute of Allergy and Infectious Diseases (NIAID)Phase 1